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Abstract
Background: It has been suggested that an increase
in oxidative stress in individuals with Down syndrome
(DS) may cause adverse effects in the cell membranes
through the oxidation of polyunsatured fatty acids.
Methods: We examined erythrocyte malondialde-
hyde (MDA) levels in 100 individuals of both sexes (34
males and 66 females) with DS, aged from newborn
to 29 years. The cytogenetic analysis revealed 90
individuals with regular trisomy 21, four individuals
with trisomy 21 by Robertsonian (Rb) translocation,
and six individuals with mosaic trisomy 21. DS indi-
viduals were divided into six age groups. The control
group consisted of 100 healthy individuals of both
sexes (40 males and 60 females) who were age-
matched with DS subjects.
Results: No significant differences were found in
erythrocyte MDA levels between the sexes in any of
the age groups for the DS group and the control
group. We confirmed significantly higher erythrocyte
levels of MDA in individuals with DS compared to the
control group. A significant difference was observed
in erythrocyte MDA levels between DS individuals
with trisomy and controls for all age groups, and in
individuals with DS due to Rb translocation trisomy.
However, in DS individuals with mosaicism, MDA lev-
els depended on the percentage of diploid and tri-
somy cells.
Conclusions: Our results confirm an increase in lipid
peroxidation in patients with DS.
Clin Chem Lab Med 2007;45:59–62.
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Introduction
Down syndrome (DS), a genetic abnormality associ-
ated with the presence of three copies of chromo-
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some 21, reported by Lejeune et al. (1), is one of the
most important human congenital diseases, occurring
in 1 out of 700–1000 live births (2). The disease is
associated with immune system disorders, autoim-
mune processes, increased incidence of heart defects,
and gastrointestinal anomalies. Higher incidence of
leukaemia and other haematological disorders is
common in affected individuals. However, the most
important features of DS are mental retardation and
accelerated ageing. Numerous studies link both of
these abnormalities to disturbances in oxygen metab-
olism. Reactive oxygen species (ROS) are substances
that are released during oxidative metabolism. ROS
include the superoxide anion (O2•–), hydrogen perox-
ide (H2O2), and the hydroxyl radical (OH•) (3). The
reaction of ROS with macromolecules can lead to
DNA mutations, changes in the structure and function
of proteins, and peroxidative cell-membrane lipids (4).
Oxidative stress may result from an excess of Cu/Zn
superoxide dismutase (SOD-1) activity in DS indivi-
duals due to an extra copy of the SOD-1 gene located
on chromosome 21.
Lipid peroxidation is an autocatalytic process that
is a common consequence of cell death, and is an
important biological consequence of oxidative cellu-
lar damage. ROS have been suggested to exert their
cytotoxic effect by peroxidation of polyunsaturated
fatty acids of the membrane, changing the permea-
bility of cellular membranes, increasing their fluidity,
their rigidity and in some cases making them lose
their integrity and increasing the risk of membrane
rupture. Malondialdehyde (MDA) is the most abund-
ant individual aldehyde resulting from lipid peroxi-
dation; thus, MDA can be considered a marker of the
lipid peroxidation (5). In this way, higher MDA levels
could contribute to oxidative stress (6). In addition,
MDA itself, because of its high chemical reactivity,
can generate other cellular alterations, both structural
and functional. MDA is generally measured by the
2-thiobarbituric acid (TBA) method, although this is
not specific for free MDA, since many other sub-
stances that can occur in biological material react
positively with TBA. In this study MDA was deter-
mined by high-performance liquid chromatography
(HPLC). This method is highly specific and accurate,
and distinguishes between true MDA and other alde-
hydes that may react with TBA (7).
In this work, we investigated MDA levels, an end-
product of lipid peroxidation, in a sample of DS indivi-
duals and a group of healthy subjects age-matched to
the DS individuals to establish any change in levels
due to oxidative stress, and matching oxidative stress
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Table 1 Erythrocyte MDA levels in individuals with DS (regular trisomy 21) and in the control group according to age.
Age, years DS individuals Control group p
n MDA, nm/mg Hb n MDA, nm/mg Hb
Newborn–1 16 112.37"5.14 20 86.92"5.14 -0.05*
2–4 17 136.25"5.06 20 114.36"5.32 -0.05*
5–9 18 161.39"5.34 18 132.68"3.09 -0.05*
10–14 14 184.75"4.16 15 156.11"5.02 -0.05*
15–19 14 228.19"5.28 15 189.36"4.71 -0.05*
20–29 11 263.36"6.15 12 217.22"5.30 -0.05*
*Statistically significant differences.
to different types of DS: regular trisomy 21, trisomy
21 caused by translocation and mosaic trisomy 21.
Materials and methods
Sample of DS individuals
We examined 100 individuals (34 males and 66 females) with
DS, aged from newborn to 29 years. These individuals had
no associated anomalies. In all individuals, DS diagnosiswas
confirmed by cytogenetic analysis, which identified 90 sub-
jects with regular trisomy 21, four subjects with Robertso-
nian (Rb) translocation trisomy t(q21q21) and six subjects
with mosaic. They were registered as outpatients in the
Social Paediatric Unit at Nin˜o Jesu´s Hospital and the Pae-
diatric Service at San Rafael Hospital, both in Madrid (Spain).
The study was approved by the Ethics Committee of the
Superior Council of Scientific Investigation in Spain. Each
participant or a legal guardian signed an informed consent
form detailing the analysis and handing of the data.
Control group
The control group comprised 100 subjects with a normal dip-
loid complement of chromosomes and clinically healthy
individuals of both sexes (40 males and 60 females), who
were age-matched with DS individuals. The subjects of the
control group were recruited from kindergarten, primary and
secondary schools in Madrid (Spain). Biological samples
were taken after prior written consent was given by parents.
The individuals with DS and control subjects were divided
into six age groups: group 1, newborn–1 year (ns20); group
2, 2–4 years (ns20); group 3, 5–9 years (ns18); group 4,
10–14 years (ns15); group 5, 15–19 years (ns15); and group
6, 20–29 years (ns12).
Blood sampling
Blood samples were obtained by venipuncture. Fresh blood
(5 mL) was collected in tubes containing lithium heparin and
stored at 0–48C. All assays were carried out within 24 h of
sampling.
Blood samples were taken according to the principles of
the Helsinki declaration.
Chromosome analysis
Chromosome analysis was performed on cultured peripheral
blood lymphocytes. Three different handing techniqueswere
used to examine the chromosomes in detail: GTG, CBG and
RHG bands.
MDA determination
MDA levels were measured in erythrocytes according to the
method of Bull and Marnett (8). Blood was centrifuged at
2500=g for 10 min and the plasma was then removed as
completely as possible. Erythrocytes were washed three
times with 0.9% NaCl solution and subsequently haemolys-
ed by addition of distilled water. The supernatant solution
was diluted by addition of acetonitrile (v/v), followed by vig-
orous mixing. The mixture was centrifuged at 3000=g for
5 min and the resulting supernatant solution was filtered
(0.2-mm pore membrane).
HPLC was performed on an LKB Bromma 2151 system
(Pharmacia LKB Bromma, Bromma, Sweden) equipped with
an LKB Bromma 2151 model diode-array UV detector and
ChromJet integration Spectra-Physics data processor
(PEMED) Production Engineering-Medical Equipment Divi-
sion (Denver, Colorado, USA), which allowed analysis of the
peak purity. An ODS Hypersil column (25 cm=4.6 mm,
5 mm) (Shandon Scientific Ltd., Runcorn, Cheshire, UK) was
used as the stationary phase. The chromatographic condi-
tions employed were: mobile phase, PO4HNa2 and myristyl
trimethylammonium bromide buffer (pH 7.4)/acetonitrile;
flow rate, 0.4 m/min; UV detection, 268 nm; chart speed,
0.5 cm/min; attenuation, 6; temperature, ambient; and injec-
tion volume, 10 ml.
The column was equilibrated at the beginning of each dai-
ly series of measurements with at least 50 mL of the eluant.
The MDA peak in the chromatogram was identified by com-
parison with a reference chromatogram of freshly prepared
free MDA. The concentration of MDA was calculated from
the area, based on a calibration chromatogram performed
with a standard solution of MDA prepared by acid hydrolysis
as described by Esterbauer et al. (9).
Statistical analysis
Data were processed using standard statistical software such
as SPSS 10.0 (SPSS Inc., Chicago, IL, USA). Results are
expressed as mean"SD. The distribution of the groups was
analysed using the Kolmogorov-Smirnov test. As both
groups showed a normal distribution, parametric statistical
methods were used. For comparison of the groups, Stu-
dent’s t-test and analysis of variance (ANOVA) were per-
formed. Differences were considered significant for p-0.05.
Results
No statistically significant differences were found in
erythrocyte MDA levels between the sexes in any age
group for the DS group and the control group. As
shown in Table 1, erythrocyte MDA levels increased
with age in both individuals with trisomy 21 and con-
trol subjects. Our results show that MDA levels were
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Table 2 Erythrocyte MDA levels in individuals with DS due to mosaic.
Karyotype Age Normal cellular line, % Trisomic cellular line, % MDA, nm/mg Hb MDA, nm/mg Hba
47,XXq21 15 months 91 9 107.38 86.92"5.14
47,XXq21 2 years 65 35 121.05 114.36"5.32
47,XXq21 3 years 19 81 129.31 114.36"5.32
47,XYq21 19 months 20 80 113.41 86.92"5.14
47,XXq21 11 years 95.70 4.30 169.05 156.11"5.02
47,XXq21 22 years 98 2 219.14 217.22"5.31
aMean"SD MDA level in age-matched control group.
Table 3 Erythrocyte MDA levels in individuals with DS due to translocations.
Karyotype Age Translocation MDA, nm/mg Hb MDA, nm/mg Hba
46,XY,der (14;21) (q10;10) 3 months Robertsonians 14: 21 109.07 112.37"7.11
46,XY,der (14;21) (q10;10) 17 years Robertsonians 14: 21 229.01 128.19"5.28
46,XY,der (14;21) (q10;10)q21 1 year Robertsonians 21: 21 111.39 112.37"7.11
47,XY,t (10;21) (q22;22)q21 17 years Reciprocal 10: 21 228.04 228.19"5.28
aMean"SD MDA level in age-matched individuals with regular trisomy 21.
significantly higher (p-0.05) in DS individuals with
regular trisomy compared to controls of all ages.
Table 2 shows erythrocyte MDA levels in six indi-
viduals diagnosed with DS caused by mosaic and in
age-matched controls. The results show that MDA
levels depend on the percentage distribution between
diploid and trisomic cellular lines. Compared to indi-
viduals belonging to the control group of similar age,
we observed that, in general, the higher the percent-
age of diploid cells, the lower are erythrocyte MDA
levels. Lower erythrocyte MDA levels could contribute
to lower oxidative stress.
Table 3 shows erythrocyte MDA levels in four indi-
viduals with DS due to Rb translocations of chromo-
some 21 compared to age-matched individuals with
regular trisomy 21. The erythrocyte MDA levels
obtained in these cases are similar to those observed
in individuals with DS due to regular trisomy 21.
Discussion
No statistically significant differences were found in
erythrocyte MDA levels between the sexes in any age
group within the DS group and the control group. Our
findings are in agreement with those reported by Gil
et al. (10), who assayed biological variations in eryth-
rocyte MDA levels in healthy subjects from newborns
to old people aged 80 years and older. However, Inal
et al. (11) found higher MDA levels in women than in
men aged 40–69 years, perhaps due to menopause
(12).
As shown in Table 1, erythrocyte MDA levels seem
to increase with age in individuals with DS caused by
regular trisomy 21 and in control subjects. Our results
show that peroxidative damage increases with the
ageing process, with a positive correlation between
MDA levels and age (DS individuals: MDA lev-
els30.20=ageq75.84; r2s0.9885; p-0.05; controls:
MDA levels25.69=ageq59.72; r2s0.9935; p-0.05).
Similar findings have been reported by Inal et al. (11).
Rodriguez et al. (13) indicated that plasma MDA levels
increase with age in healthy subjects, while Nohl (14)
reported accumulation of lipid peroxidation products
during ageing.
Interestingly, our results show that MDA levels
were significantly higher (p-0.05) in DS individuals
with regular trisomy compared to control groups of
all ages. Our findings are in agreement with urine
MDA levels in DS patients reported by Jovanovic et
al. (15) and serum MDA in DS patients reported by
Muchova´ et al. (16). However, our data show some
differences when compared with erythrocyte MDA
levels calculated by Muchova´ et al. (16) for 37 DS
patients using the TBA reaction. These discrepancies
may be due to the different methods used to deter-
mine MDA or differences in the study populations.
Zitnanova et al. (17) detected no change in 4-
hydroxy-2-nonenal (4-HNE) levels in plasma of pati-
ents with DS compared to healthy controls. 4-HNE,
another end product of lipid peroxidation, is not a sta-
ble product of oxidative damage to lipids. It may be
continuously removed or detoxified by various path-
ways (18).
Table 2 shows erythrocyte MDA levels in the six
individuals analysed with DS caused by mosaic and
in age-matched controls. The results indicate that
MDA levels depend on the percentage distribution
between diploid and trisomic cell lines. Compared to
control subjects of similar ages, we observed that, in
general, the higher the percentage of diploid cells, the
lower are erythrocyte MDA levels; these lower levels
could contribute to lower oxidative stress.
Table 3 shows erythrocyte MDA levels in four indi-
viduals with DS due to Robertsonians translocations
of chromosome 21. The erythrocyte MDA levels ob-
tained in these cases are similar to those observed in
individuals with DS due to regular trisomy 21. These
results are in accordance with those reported by Gar-
ber et al. (19) and Jeziorowska et al. (20), who report-
ed elevated SOD-1 activity in red blood cells in cases
of translocation trisomy 21 t(q21q21).
Higher mean levels of biomarkers of oxidative
stress indicate an increased rate of oxidative damage
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in individuals with DS characterised by excess SOD-
1 activity in all cells (21). It has been argued (22, 23)
that excess SOD-1 can catalyse surrogate reactions, a
peroxidase function that generates hydroxyl radicals
from hydrogen peroxide. The hydroxyl radical is high-
ly damaging. It reacts with DNA and RNA to produce
altered base products, cross-links and strand breaks,
with proteins to inactivate enzymes, and with lipids to
initiate lipid peroxidation by oxidation of polyunsat-
urated fatty acids (24). The involvement of hydroxyl
radicals in DS could be caused by the increase in
erythrocyte MDA levels, an end product of lipid
peroxidation.
In summary, our data are consistent with the
hypothesis that an imbalance in antioxidant enzymes
may have adverse effects on cell membranes through
the indiscriminate oxidation of susceptible molecules
such as polyunsaturated fatty acids. Cells need to
maintain a balance between the first- and second-step
antioxidant enzymes to prevent the excessive gener-
ation of hydroxyl radicals. We conclude that erythro-
cyte MDA levels in DS with regular trisomy 21 and in
DS with Rb translocation trisomy 21 (which are simi-
lar to regular trisomy 21 because the Rb translocation
includes gene for SOD-1) are age-dependent and
depend on the oxidative imbalance of the antioxidant
enzymes in these individuals. Further studies involv-
ing individuals with mosaic DS will help to elucidate
the relationship between erythrocyte MDA levels and
the consequences of oxidative stress.
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